Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
The global market for Rheumatoid Arthritis Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Rheumatoid Arthritis Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rheumatoid Arthritis Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Rheumatoid Arthritis Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rheumatoid Arthritis Devices by region & country, by Type, and by Application.
The Rheumatoid Arthritis Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Devices.
Market Segmentation
By Company
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
Segment by Type:
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application
Elderly
Young adults
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rheumatoid Arthritis Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rheumatoid Arthritis Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Rheumatoid Arthritis Devices Product Introduction
1.2 Global Rheumatoid Arthritis Devices Market Size Forecast
1.2.1 Global Rheumatoid Arthritis Devices Sales Value (2019-2030)
1.2.2 Global Rheumatoid Arthritis Devices Sales Volume (2019-2030)
1.2.3 Global Rheumatoid Arthritis Devices Sales Price (2019-2030)
1.3 Rheumatoid Arthritis Devices Market Trends & Drivers
1.3.1 Rheumatoid Arthritis Devices Industry Trends
1.3.2 Rheumatoid Arthritis Devices Market Drivers & Opportunity
1.3.3 Rheumatoid Arthritis Devices Market Challenges
1.3.4 Rheumatoid Arthritis Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rheumatoid Arthritis Devices Players Revenue Ranking (2023)
2.2 Global Rheumatoid Arthritis Devices Revenue by Company (2019-2024)
2.3 Global Rheumatoid Arthritis Devices Players Sales Volume Ranking (2023)
2.4 Global Rheumatoid Arthritis Devices Sales Volume by Company Players (2019-2024)
2.5 Global Rheumatoid Arthritis Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Rheumatoid Arthritis Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Rheumatoid Arthritis Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Rheumatoid Arthritis Devices
2.9 Rheumatoid Arthritis Devices Market Competitive Analysis
2.9.1 Rheumatoid Arthritis Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Rheumatoid Arthritis Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Implantable Joint Prostheses
3.1.2 Spinal Devices
3.1.3 Other
3.2 Global Rheumatoid Arthritis Devices Sales Value by Type
3.2.1 Global Rheumatoid Arthritis Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rheumatoid Arthritis Devices Sales Value, by Type (2019-2030)
3.2.3 Global Rheumatoid Arthritis Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Rheumatoid Arthritis Devices Sales Volume by Type
3.3.1 Global Rheumatoid Arthritis Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Rheumatoid Arthritis Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Rheumatoid Arthritis Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Rheumatoid Arthritis Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Elderly
4.1.2 Young adults
4.2 Global Rheumatoid Arthritis Devices Sales Value by Application
4.2.1 Global Rheumatoid Arthritis Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rheumatoid Arthritis Devices Sales Value, by Application (2019-2030)
4.2.3 Global Rheumatoid Arthritis Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Rheumatoid Arthritis Devices Sales Volume by Application
4.3.1 Global Rheumatoid Arthritis Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Rheumatoid Arthritis Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Rheumatoid Arthritis Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Rheumatoid Arthritis Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Rheumatoid Arthritis Devices Sales Value by Region
5.1.1 Global Rheumatoid Arthritis Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rheumatoid Arthritis Devices Sales Value by Region (2019-2024)
5.1.3 Global Rheumatoid Arthritis Devices Sales Value by Region (2025-2030)
5.1.4 Global Rheumatoid Arthritis Devices Sales Value by Region (%), (2019-2030)
5.2 Global Rheumatoid Arthritis Devices Sales Volume by Region
5.2.1 Global Rheumatoid Arthritis Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Rheumatoid Arthritis Devices Sales Volume by Region (2019-2024)
5.2.3 Global Rheumatoid Arthritis Devices Sales Volume by Region (2025-2030)
5.2.4 Global Rheumatoid Arthritis Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Rheumatoid Arthritis Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Rheumatoid Arthritis Devices Sales Value, 2019-2030
5.4.2 North America Rheumatoid Arthritis Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Rheumatoid Arthritis Devices Sales Value, 2019-2030
5.5.2 Europe Rheumatoid Arthritis Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Rheumatoid Arthritis Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Rheumatoid Arthritis Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Rheumatoid Arthritis Devices Sales Value, 2019-2030
5.7.2 South America Rheumatoid Arthritis Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Rheumatoid Arthritis Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Rheumatoid Arthritis Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rheumatoid Arthritis Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rheumatoid Arthritis Devices Sales Value
6.2.1 Key Countries/Regions Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Rheumatoid Arthritis Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.3.2 United States Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.4.2 Europe Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.5.2 China Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.6.2 Japan Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.7.2 South Korea Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rheumatoid Arthritis Devices Sales Value, 2019-2030
6.9.2 India Rheumatoid Arthritis Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rheumatoid Arthritis Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Active Implants LLC
7.1.1 Active Implants LLC Company Information
7.1.2 Active Implants LLC Introduction and Business Overview
7.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Offerings
7.1.5 Active Implants LLC Recent Development
7.2 Anika Therapeutics, Inc.
7.2.1 Anika Therapeutics, Inc. Company Information
7.2.2 Anika Therapeutics, Inc. Introduction and Business Overview
7.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Offerings
7.2.5 Anika Therapeutics, Inc. Recent Development
7.3 Arthrex, Inc.
7.3.1 Arthrex, Inc. Company Information
7.3.2 Arthrex, Inc. Introduction and Business Overview
7.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Offerings
7.3.5 Arthrex, Inc. Recent Development
7.4 Asahi Kasei Pharma Corporation
7.4.1 Asahi Kasei Pharma Corporation Company Information
7.4.2 Asahi Kasei Pharma Corporation Introduction and Business Overview
7.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Offerings
7.4.5 Asahi Kasei Pharma Corporation Recent Development
7.5 B. Braun Melsungen AG
7.5.1 B. Braun Melsungen AG Company Information
7.5.2 B. Braun Melsungen AG Introduction and Business Overview
7.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Offerings
7.5.5 B. Braun Melsungen AG Recent Development
7.6 CONMED Corporation
7.6.1 CONMED Corporation Company Information
7.6.2 CONMED Corporation Introduction and Business Overview
7.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Offerings
7.6.5 CONMED Corporation Recent Development
7.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
7.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Company Information
7.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Introduction and Business Overview
7.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Offerings
7.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Development
7.8 Integra Lifesciences Corporation
7.8.1 Integra Lifesciences Corporation Company Information
7.8.2 Integra Lifesciences Corporation Introduction and Business Overview
7.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Offerings
7.8.5 Integra Lifesciences Corporation Recent Development
7.9 Johnson & Johnson (DePuy Synthes Inc.)
7.9.1 Johnson & Johnson (DePuy Synthes Inc.) Company Information
7.9.2 Johnson & Johnson (DePuy Synthes Inc.) Introduction and Business Overview
7.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Offerings
7.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Development
7.10 Novartis AG
7.10.1 Novartis AG Company Information
7.10.2 Novartis AG Introduction and Business Overview
7.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis AG Rheumatoid Arthritis Devices Product Offerings
7.10.5 Novartis AG Recent Development
7.11 RTI Surgical, Inc.
7.11.1 RTI Surgical, Inc. Company Information
7.11.2 RTI Surgical, Inc. Introduction and Business Overview
7.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Offerings
7.11.5 RTI Surgical, Inc. Recent Development
7.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
7.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Company Information
7.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Introduction and Business Overview
7.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Offerings
7.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Development
7.13 Setpoint Medical Corporation
7.13.1 Setpoint Medical Corporation Company Information
7.13.2 Setpoint Medical Corporation Introduction and Business Overview
7.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Offerings
7.13.5 Setpoint Medical Corporation Recent Development
7.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
7.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Company Information
7.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Introduction and Business Overview
7.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Offerings
7.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Development
7.15 Stryker Corporation (OrthoSpace Ltd.)
7.15.1 Stryker Corporation (OrthoSpace Ltd.) Company Information
7.15.2 Stryker Corporation (OrthoSpace Ltd.) Introduction and Business Overview
7.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Offerings
7.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Development
7.16 UCB Pharma S.A.
7.16.1 UCB Pharma S.A. Company Information
7.16.2 UCB Pharma S.A. Introduction and Business Overview
7.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Offerings
7.16.5 UCB Pharma S.A. Recent Development
7.17 Zimmer Biomet
7.17.1 Zimmer Biomet Company Information
7.17.2 Zimmer Biomet Introduction and Business Overview
7.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Offerings
7.17.5 Zimmer Biomet Recent Development
8 Industry Chain Analysis
8.1 Rheumatoid Arthritis Devices Industrial Chain
8.2 Rheumatoid Arthritis Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rheumatoid Arthritis Devices Sales Model
8.5.2 Sales Channel
8.5.3 Rheumatoid Arthritis Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
听
听
*If Applicable.
